Sep 23, 2026 9 0
Uploaded by River Wang
Favorite
Share
More Options
7
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR) - a single-arm phase II trial_Page 1

Open in WPS to view all 7 pages